Shanghai - Delayed Quote CNY

InventisBio Co., Limited (688382.SS)

21.80
-0.61
(-2.72%)
As of 10:13:07 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
77,513.35
185,526.87
--
--
--
Gross Profit
70,482.31
185,526.87
--
--
--
Operating Expense
445,157.12
500,736.34
519,444.14
357,943.63
--
Operating Income
-374,674.81
-315,209.48
-519,444.14
-357,943.63
--
Net Non Operating Interest Income Expense
36,337.98
32,845.88
15,112.41
11,405.18
431.62
Pretax Income
-348,019.90
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Net Income Common Stockholders
-348,019.90
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Basic EPS
-0.60
-0.49
-0.95
-0.78
-2.29
Diluted EPS
-0.60
-0.49
-0.95
-0.78
-2.29
Basic Average Shares
580,754.09
579,541.38
508,931.59
458,860.87
460,021.31
Diluted Average Shares
580,754.09
579,541.38
508,931.59
458,860.87
460,021.31
Total Operating Income as Reported
-348,019.90
-283,975.27
-483,305.48
-357,911.47
-1,053,448.80
Rent Expense Supplemental
--
256.24
492.25
484.47
2,559.36
Total Expenses
452,188.17
500,736.34
519,444.14
357,943.63
--
Net Income from Continuing & Discontinued Operation
-348,019.90
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Normalized Income
-337,161.14
-274,628.02
-483,490.51
-357,865.53
-1,053,448.80
Interest Income
41,158.53
33,894.35
17,379.10
12,763.86
555.09
Interest Expense
--
182.89
1,031.52
1,191.27
--
Net Interest Income
36,337.98
32,845.88
15,112.41
11,405.18
431.62
EBIT
-362,316.83
-283,792.39
-482,453.49
-356,720.21
--
EBITDA
-362,316.83
-266,133.08
-466,840.46
-345,615.75
414.44
Reconciled Depreciation
--
17,659.30
15,613.03
11,104.46
414.44
Net Income from Continuing Operation Net Minority Interest
-348,019.90
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Total Unusual Items Excluding Goodwill
-10,858.76
-9,347.26
5.50
-45.95
212.05
Total Unusual Items
-10,858.76
-9,347.26
5.50
-45.95
212.05
Normalized EBITDA
-351,458.07
-256,785.82
-466,845.95
-345,569.80
414.44
12/31/2020 - 7/25/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1875.HK TOT BIOPHARM-B
2.050
0.00%
 
MTNB Matinas BioPharma Holdings, Inc.
0.5950
+1.71%
 
IDYA IDEAYA Biosciences, Inc.
19.07
+1.33%
 
PTCT PTC Therapeutics, Inc.
49.55
-0.80%
 
ZLAB Zai Lab Limited
33.80
+0.54%
 
ARVN Arvinas, Inc.
9.14
+0.77%
 
VKTX Viking Therapeutics, Inc.
25.66
-0.50%